Mukherjee, A. and Roy , S. and Patidar, A. and Bodhale, N. and Dandapat, J. and Saha , B. and Sarkar , A. (2021) TLR2dimer-specific ligands selectively activate protein kinase C isoforms inLeishmania infection. Immunology, 164 (2). pp. 318-331. ISSN 2021 Oct;164(2):318-331.

Shukla , D. and Patidar, A. and Sarma , U. and Chauhan, P. and Pandey, SP. and Chandel, HS. and Bodhale, N. and Ghosh , SK. and Guzman, CA. and Ebensen , T. and Silvestre, R. and Sarkar, A. and Saha , B. and Bhattacharjee, S. (2021) Interdependencies between Toll-like receptors in Leishmania infection. Immunology, 164 (1). pp. 173-189.

Kumar, S. and Zutshi, S. and Patidar, A. and Bodhale, N. and Roy, S. and Sarkar, A. and Saha, B. (2019) LmjMAPK10offers protection against Leishmania donovani infection. Parasite Immunology.

Patidar, A. and Selvaraj, S. and Sarode, A. and Chauhan, P. and Chattopadhyay, D. and Saha, B. (2018) DAMP-TLR-cytokine axis dictates the fate of tumor. Cytokine, 104. pp. 114-123.

Shukla, D. and Chandel, H.S. and Srivastava, S. and Chauhan, P. and Pandey, S.P. and Patidar, A. and Banerjee, R. and Chattopadhyay, D. and Saha, B. (2018) TLR11 or TLR12 silencing reduces Leishmania majorinfection. Cytokine, 104. pp. 110-113.

Patidar , A. and Selvaraj , S. and Sarode , A. and Chauhan , P. and Chattopadhyay , D. and Saha , B. (2017) DAMP-TLR-cytokine axis dictates the fate of tumor. Cytokine. 2017 Oct 9. pii: S1043-4666 (17) 30296-X., S1043- (4666). (17)-30296-X..

Shukla , D. and Chandel , H.S. and Srivastava , S. and Chauhan , P. and Pandey , S.P. and Patidar , A. and Banerjee , R. and Chattopadhyay , D. and Saha , B. (2017) TLR11 or TLR12 silencing reduces Leishmania majorinfection. Cytokine. 2017 Oct 7. pii: S1043-4666(17)30295-8, S1043 (4666(1). pp. 30295-30298.

Selvaraj , S. and Raundhal , M. and Patidar , A. and Saha , B. (2014) Anti-VEGF antibody enhances the antitumor effect of CD40. International Journal of Cancer, 135. pp. 1983-1988.